Bio-Rad Laboratories, Inc. is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, its products advance the discovery process and improve healthcare. Bio-Rad's customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology and pharmaceutical companies, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with more than 7,800 employees worldwide. Bio-Rad had revenues exceeding $2.5 billion in 2020.
Financial Statements
- Click here to download Bio-Rad Laboratories Inc.'s Income Statement
- Click here to download Bio-Rad Laboratories Inc.'s Balance Sheet
- Click here to download Bio-Rad Laboratories Inc.'s Statement of Cash Flows
Key Info
- Industry: Analytical Laboratory Instrument Manufacturing
- Sector: Manufacturing
- CEO Name: Norman Schwartz
Key Statistics
- Stock Price: $417.14
- Dividend Yield: 0%
- Market Capitalization: $12,422,793,239
- Shares Outstanding: 24,633,863
- Number of Employees: 8,000
- Trailing 12-Month EPS: $-64.63
- Trailing 12-Month DPS: $0
- Payout Ratio: -0.0%
Important Dates
- Next Earnings Date: 2022-10-27
- Next Ex-Dividend Date:
Price Trends
- Current Stock Price: $417.14
- 52-week high: $798.97
- 52-week low: $406.24
- 200-day moving average: $516.11
- 50-day moving average: $479.61
Performance
- 1-Month Price Return: -14.3%
- 3-Month Price Return: -15.7%
- 6-Month Price Return: -28.1%
- 1-Year Price Return: -44.2%
- 2-Year Price Return: -18.8%
- 5-Year Price Return: 88.2%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast